Evidence map›Paper›PMID 32024513›Full record

ArticleBMC complementary medicine and therapies2020

Evaluation of the hepatoprotective effect of Yigan mingmu oral liquid against acute alcohol-induced liver injury in rats.

Qigui Mo, Gao Zhou, Baibo Xie, Bingxin Ma, Xinyu Zang, Yuxin Chen, Linyou Cheng, James Hua Zhou, Youwei Wang

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Mechanism of the Effect of CompoundDrug design, development and therapy · 2023
    Article
  3. Article
  4. Article
  5. The Protective Effects ofFrontiers in pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Qigui MoInstitute of TCM and Natural Products, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, People's Republic of China.
Gao ZhouInstitute of TCM and Natural Products, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, People's Republic of China.
Baibo XieBeijing Hebabiz Biotechnology Co. Ltd, Beijing, 102206, People's Republic of China.
Bingxin MaInstitute of TCM and Natural Products, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, People's Republic of China.
Xinyu ZangBeijing Hebabiz Biotechnology Co. Ltd, Beijing, 102206, People's Republic of China.
Yuxin ChenInstitute of TCM and Natural Products, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, People's Republic of China.
Linyou ChengGuangxi Hebabiz Pharmaceutical Co. Ltd, National and Region joint Engineering Center for Anticancer Drug Development, Qinzhou, 535008, People's Republic of China.
James Hua ZhouBeijing Hebabiz Biotechnology Co. Ltd, Beijing, 102206, People's Republic of China. drjge@163.com.
Youwei WangInstitute of TCM and Natural Products, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, People's Republic of China. wyw@whu.edu.cn.ORCID http://orcid.org/0000-0003-2880-787X
Wuhan University · CNBeijing VDJBio (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundYigan mingmu oral liquid (YGMM) is a herbal medicine based on a famous Chinese herbal formula that has been used for sore eyes for more than 400 years. Eye health is closely associated with the liver based on TCM. This study aimed to investigate the hepatoprotective effect of YGMM against acute liver injury induced by alcohol in rats.

methodsExperimental rats were administered with silymarin and YGMM through the gastric gavage during the entire experiment. Starting from the 11th day, the rats were administered orally with 14 ml/kg Red Star Erguotou Liquor, a popular brand, at 4 h after the dose of silymarin (100 mg/kg) and YGMM (1, 2.5 and 5 ml/kg in low, middle and high dosage group, respectively) once a day for 4 weeks except for the rats in the normal group. Biochemical parameters, including ALT, AST, TB, TG, T-SOD, GSH, and MDA were detected to evaluate the protective effect of YGMM. Pathological changes were observed through histopathological examination.

resultsTreatment with YGMM exhibited a significant protective effect by reversing the biochemical parameters (ALT, AST, TB, TG, and GSH) and histopathological changes. Histopathological examination by Oil Red O Staining Solution showed that lipid droplets were significantly reduced in the silymarin and YGMM groups (p < 0.001) when compared to alcohol group.

conclusionsYGMM exhibits a significant hepatoprotective activity against acute liver injury induced by alcohol in rats.

Indexed as

Plants, MedicinalAnimalsChemical and Drug Induced Liver InjuryDisease Models, AnimalDrugs, Chinese HerbalLiverMaleRatsRats, Sprague-DawleyTransaminasesDrugs, Chinese HerbalTransaminasesAlcoholAlcoholic liver diseaseHepatoprotectiveOxidative stressYigan mingmu oral liquid

Identifiers

PMID32024513
PMCPMC7076881
OpenAlexW3010232443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.